ABSTRACT
INTRODUCTION
Ascites is the most common of the three major complications of cirrhosis together with hepatic encephalopathy and variceal hemorrhage. The development of fl uid retention in the setting of cirrhosis is an important landmark in the natural history of chronic liver disease. Approximately 50% of patients with compensated cirrhosis, develop ascites during 10 years of observation [1] and 50% of them succumb in two years, [2] which has led to the inclusion of ascites as one of the indications for initiating evaluation for liver transplantation. [3] Educations regarding dietary sodium restriction and oral diuretics have long been the mainstays of treatment of patients with cirrhosis and ascites. [4, 5] This approach, has been shown to be effective in 90% of patients, however 10% lack response to high doses of diuretics or have recurrent side effects, (e.g., hepatic encephalopathy, hyponatremia, hyperkalemia, or azotemia) even when lower doses are given, and they are defi ned as having refractory Ascites. [6, 7] Current therapeutic strategies for refractory ascites include repeated large-volume paracentesis (LVP) with the use of plasma expanders and transjugular intrahepatic portosystemic shunts (TIPS). [8, 9] Comparisons with administration of diuretics at increasing doses (maximal doses, 400mg of spironolactone per day and 160mg of furosemide per day) until loss of ascetic fl uid is achieved, favors paracentesis as the method of choice, [7, 10] because it is faster, more effective and is associated with fewer adverse events than diuretic therapy. [11] [12] [13] Although TIPS is effective and prevents recurrence in patients with refractory ascites [9, 14] the disadvantages of this technique which include recurrence of ascites, hepatic encephalopathy, high cost and lack of availability in some centers limit its use. [15] [16] [17] [18] Recently the Consensus Conference of the International Ascites Club has recommended that gross ascites should be treated with therapeutic paracentesis followed by colloid volume expansion, and diuretic therapy, and that repeated LVP may be the fi rst line treatment of refractory ascites. [19] However, the removal of large amounts of ascitic fl uid may induce an impairment of circulatory function that has been termed paracentesis-induced circulatory dysfunction (PICD), fi rst described by . [20] This is a hyperdynamic state that can appear up to 6 days after the paracentesis and is related to marked activation of the renin-angiotensin system. [21, 22] It is associated with a rapid return of ascites, renal failure, and a worsened prognosis and may require medical intervention and frequent hospitalization. [23] Moreover, PICD is not spontaneously reversible and patients who develop this disorder show a reduced survival. [24] The objectives of the present study were: 1. To estimate the rate of PICD after LVP in cirrhotic patients with tense/refractory ascites. 2. To identify the pretreatment predictors that may allow the selection of the most appropriate candidate for large volume paracentesis. 3. To asses the clinical and hemodynamic changes associated with LVP and their relation with PICD.
PATIENTS AND METHODS

Study design
This study was conducted as a comparative study of cirrhotic patients with massive ascites before and after large-volume paracentesis Outcome factor PICD was defi ned as increase in plasma renin activity (PRA) of more than 50% of pretreatment value to level greater than 7.5 ng /ml/ hour on the 6th day after paracentesis Gines et al, 1996 [24] Prognostic factors Age, sex, severity of liver disease (Child-Pugh grade), comorbid conditions (DM, HTN, IHD), electrolytes (sodium and potassium), Creatinine level, Plasma expander given (dextran 70 or human albumin), and amount of fl uid aspirated.
Methods
Elligible patients from the outpatient clinic or emergency department were admitted to the hospital until at least one week after paracentesis. During hospital stay patients received adequate treatment according to their condition including low salt diet and diuretics.
All patients were subjected to the following:
History and physical examination: including vital signs, general signs of liver failure, assessment for encephalopathy, cardiac and abdominal examination.
Laboratory investigations: including: Complete blood picture, ALT and AST, serum albumin, serum bilirubin, PT, serum creatinine, serum electrolytes (Na and K), random blood sugar and PRA. All samples for laboratory tests were collected immediately before and at 6th days after paracentesis
The routine hematological and biochemical studies were performed using standard laboratory techniques.
Samples for PRA were obtained through a catheter inserted in a peripheral vein with the patient lying supine and rested in bed for an adequate time. The samples were collected at room temperature in tubes containing EDTA-K and immediately centrifuged. The plasma obtained was then frozen (-30°C) until analyzed. PRA was measured by a commercial kit to estimate the generation of angiotensin 1 by radioimmunoassay. The normal value for PRA was 4.5-7.5ng/ml/hour
Abdominal ultrasonography: was performed before the paracentesis using the HITACHI EUB 200 machine with linear probe.
D-Doppler echocardiography:
Echocardiographic evaluation was performed before and on the 2nd day after paracentesis using a Hewlett-Packard phased array (Sons 1800, USA made, model: DR 53 15) ultrasonoscope using a 2.5 and 3.5 MHz phased array transducer probe using the left parasternal view (M-Mode and the apical four-chamber subcostal view (B-Mode) according to the American Society of echocardiography convention. In the apical four-chamber view a doppler recording of diastolic mitral fl ow was obtained by positioning the sample volume on the infl ow area of the left ventricle just below the level of the mitral annulus. Measurements obtained were cardiac output, pulmonary artery pressure, wall thickness (left ventricular posterior wall thickness and inter ventricular septum thickness) left ventricular systolic, diastolic function and other cardiac abnormalities. Measurements derived from at least three cardiac cycles were averaged. The systolic function was evaluated by the ejection fraction of the left ventricle while diastolic function was evaluated by E /A ratio.
Large volume paracentesis: was performed on the second day of admission as described in detail by Tito et al, 1990 . [25] An 18 -16 g cannula with an inner sharp metal needle was inserted under strict aseptic conditions in the left lower abdominal quadrant. Once the needle entered the peritoneal cavity, the inner part was removed and ascetic fl uid was drained into a sterile container. The process continued till at least 8 L -and short of total paraceentesis -were drained over a 2 hours period.
Intravenous infusion of Dextran70 6% was given during the paracentesis (100 C.C per each liter of ascitic fl uid removed) or Salt-Free Human Albumin (SFHA) (8g\L per each liter of ascetic fl uid removed, 50% of the dose within the fi rst 2 hours and 50% 8 hours after paracentesis).
Fresh frozen plasma was given for patients with prolonged prothrombin time, and Platelets transfusion was given to patients with thrombocytopenia (below 40.000/c.c.)
Statistical analysis
Descriptive statistical methods were used for data analysis and results were expressed as range or means with standard deviation (mean ± SD). Differences between groups were assessed by using parametric tests, continuous variables were assessed by using paired T test or Kruskl-Wallis test (if the variance was not homogenous) Qualitative variables were presented as frequencies, and differences were assessed by using Chi square (χ 2 )-Mc Nemur test. The level of statistical signifi cance was set at P < 0.05. A best fi tting logistic regression model was done to identify the independant predictors of PICD from all the signifi cant different variables by univariate analysis.
RESULTS
Forty fi ve patients presenting with massive cirrhotic ascites who were consecutively admitted to the hospital were included in the study. The baseline demographic, clinical and laboratory characteristics of the study patients are presented in Table 1 . They were 27 males (60%) and 18 females (40%), and their ages ranged between 26 and 79 years (mean 51.2 ± 10.64). Cirrhosis was due to chronic virus C hepatitis in the vast majority of cases and only a few had HBV or combined infection and none gave history of alcoholism. Jaundice was present in 29 (64%), peripheral edema in 37 (82%) and bleeding tendency (epistaxis / bleeding gums) in 5 (11.1%). Hypertension and Diabetes Mellitus was present in 7 (15.6%) and 9 (20%) respectively and Grade 1 encephalopathy was present in 6 (13.3%).
The mean value of Hb (mean 9.93 ± 1.84), hamatocrit (mean 29.3 ± 5.6) and platelets count (mean 124 ± 77) were lower than normal. S albumin (mean2.03 ± 0.46) was also decreased while serum bilirubin (mean 2.033 ± 1.67) was elevated and PT (mean 14.99 ± 2.44) was prolonged. S. creatinine (mean 1.35 ± 0.87), S. Na (mean 134.1 ± 9.4) and S. K (4.3 ± 0.68) and random blood sugar (mean 142.8 ± 104.9) were within normal levels. It is worth mentioning that all the study subjects were classifi ed as Child -Pugh class C according to the clinical and laboratory fi ndings. Table 2 describes the pertinent ultrasonographic fi ndings in the study subjects. As expected most of the cases had a shrunken liver (60%) while only 24.4% had hepatomegaly. The portal vein was dilated in 55.6% of cases (mean 13.4 ± 1.4mm). The spleen was also enlarged in most cases (mean 15.5 ± 5.2cm) and the splenic vein was dilated in 60.0% of cases (mean 10.05 ± 4.3mm).
The paracentesis procedure events, PRA before and after, and the frequency of PICD in the total study subjects and outcome groups are presented in Table 3 . Paracentesis was done after 24 hours of admission for each patient. The volume of fl uid aspirated ranged between 8 and 18 liters (mean 9.9 ± 4.0). The plasma expander used was Dextran in 32 (71.1%) and Albumin in 13 (28.9%) of patients. The mean PRA increased from 8.3 ± 6.3 ng/l/hr before to 18.3 ± 10.3 after paracentesis and PICD occurred in 33 (73.3%) of patients.
Accordingly the patients were classifi ed into the 2 outcome groups; with and without PICD. As shown in Table 3 there was no signifi cant difference in mean volume of aspirated fl uid between the 2 groups. However, there was a highly signifi cant statistical difference in the type of plasma expander used between them (P = 0.002 Although PRA was slightly higher at baseline among the group that developed PICD, the difference was not statistically signifi cant. The mean PRA increased from 8.98 ± 5.22 to 23.97 ± 6.62 in those who developed PICD and only from 7.27 ± 7.85 to 9.09 ± 8.59 in those who did not and the difference post paracentesis was highly statistically signifi cant (P < 0.001).
Comparison of the possible risk factors of PICD between the outcome groups is shown in Table 4 and Table 5 .
The mean age was signifi cantly lower among those who developed PICD (48.8 ± 9.6) than those who did not (57.8 ± 10.9). There was no signifi cant difference between the 2 groups as regards gender or clinical variables except diabetes mellitus which was signifi cantly more frequent among those who did not develop PICD [ Table 4 ]. Similarly, there was no signifi cant differences between hematological, biochemical and electrolyte laboratory variables among those who developed PICD and those who did not, except for the mean random blood glucose which was signifi cantly higher among those who did not develop PID (188.4 ± 111.9) than those who did (123.5 ± 98.0) [ Table 5 ].
The best fi tting stepwise logistic regression model for occurrence of circulatory dysfunction as a dependant variable, verses various personal and disease characteristics as independent variables [ Table 6 ], has identifi ed younger age and Dextran (type of plasma expander used) as the only independent signifi cant risk factors with OR and 95% CI (0.88, 0.80 -0.97) for the former and (21.79, 3.01 -157.58) for the latter. The 2 variables explained 51% of the model (R-square = 0.51) which was highly statistically signifi cant (P < 0.0001).
The haemodynamic status of the study patients before LVP (at base line) and 48 hours after are shown in Table 7 .
At base line the mean heart rate (HR) (87.5 ± 8.3) and cardiac output (COP) (7.5 ± 1.9) were higher than the normal range, while mean arterial pressure (98.4 ± 20.8) was lower than normal,. The ejection fraction (EF) (58.7 ± 9.99), the posterior wall thickness (PwT0) (1.0 ± 0.2) and inter ventricular wall thickness (IVwT) (1.0 ± 0.2) were within normal limits. The EA ratio (0.9 ± 0.3) was lower than normal values and pulmonary artery pressure (PAP) (31.7 ± 15.2) was markedly increased. Forty eight hours after LVP there was signifi cant increase in HR to (95.5 ± 9.5) and COP to (8.3 ± 2.3) and signifi cant decrease in MAP to (90.7 ± 14.4). On the other hand there was no signifi cant change in EF, EA ratio, PAP or PwT and IVwT. Table 8 shows comparison between those who developed PICD and those who did not as regards hemodynamic status at base line, 48 hours post-LVP and the mean before/after change. There was no statistically signifi cant difference in haemodynamic parameters between the 2 groups before or after LVP except HR and IVwT which were signifi cantly slightly higher among those who did not develop PICD only at base line (P = 0.03 and 0.04 respectively). The HR increased (8.3 ± 0.97 and 6.92 ± 1.57 respectively, P = 0.001 for both) and COP increased (0.9 ± 0.22, P =0.001 and 0.88 ± 0.37, P =0.38 respectively) and MAP decreased (-8.38 ± 2.6, P =0.002 and -6.42 ± 3.22, P = 0.071 respectively). There was no signifi cant change in the other echcardiographic parameters namely: EF, E/A ratio, PAP, PwT or IVwT among the 2 groups. 
DISCUSSION
Therapeutic paracentesis of 6 liters or more of ascetic fl uid is a recommended option for the treatment of tense developed PICD. This fi gure is higher than reported by other studies using plasma expanders. It has been reported that PICD occurs in 80% of patients not receiving plasma expenders. [33] This might be attributed to the fact that over 70% of our patients received Dextran 70 as a plasma expander and only less than 30% received Salt Free Human Albumin (SFHA). PICD developed in 88% of those who received Dextran and only 38% of those who received SFHA This is in congruence with the fi nding of , [34] Gines, et al, 1996 [24] and Sola-Vera et al, 2003, [35] who found that the incidence of PICD was nearly double in patients receiving Dextran 70 6% compared with those who received SFHA (51% -33% Vs 18% -11%). An inverse relationship between the incidence of PICD and the halflife of the plasma expander used (days for Dextran-70, and weeks for salt free human albumin) has been reported. [21] Although there was no signifi cant difference in the mean volume of ascetic fl uid removed between the 2 groups, the fact that our attempt to reach near total paracentesis, has led to the evacuation of 8 liters or more in all our patients with a mean of about 10 liters which might have contributed to the high incidence of PICD in this study. [35] This study had showed that albumin is more effective than saline in the prevention of PICD. Saline is a valid alternative to albumin when less than 6 L of ascitic fl uid is evacuated.
By univariate analysis, only age, presence of diabetes mellitus (DM), and the level of random blood glucose were signifi cantly different between those who developed PICD and those who did not. No other factors studied as predictors in this work whether demographic, clinical, laboratory orsonographic were found to be signifi cantly different. Interestingly, those who developed PICD were younger and DM was less frequent among them. However, the logistic regression model in this study has shown that the only two independent risk factors of PICD are younger age and the use of Dextran as expender. In the recent study of Sola-Vera et al, 2003 , only the type of plasma expander out or refractory cirrhotic ascites. However, it has been linked with circulatory dysfunction associated with increased plasma rennin activity. This study was designed to assess the frequency and risk factors of parcentesis induced circulatory dysfunction (PICD) in our patients and to assess the haemodynamic and echocardigraphic changes associated with LVP and their relation with PICD. Forty fi ve patients with post-hapatic cirrhosis with Child Pugh grade C and massive or refractory ascites were subjected to LVP. The clinical, laboratory and ultrasonographic fi ndings of the study group are quite typical of this category of patients.
All of the patients experienced marked relief of the abdominal distension following the LVP and none developed serious complications in the form of SBP, sepsis, bleeding or increase in the grade of encephalopathy until discharge after one week at least. Procedure-associated risks have been reported to be low and include a 1% chance of signifi cant abdominal-wall hematoma, 0.01% chance of hemoperitoneum, and a 0.01% chance of iatrogenic infection related to paracentesis, [26, 27] but none of these occurred in this study. Degricija et al, 2003 [28] also reported no systemic or local complications after removal of 6 liters of ascetic fl uid in 50 patients. Several large randomized, controlled trials have shown that repeated large-volume paracentesis is safer and more effective for the treatment of tense ascites compared with larger-than-usual doses of diuretics. [29] [30] [31] Total paracentesis has also been shown to be as safe as repeated partial paracentesis and to shorten the period of hospitalization and may even be performed on an outpatient basis. [25] The fact that none of the patients who developed PICD had any complications attests that this disturbance is usually silent on the short term and so has been considered by some authors to be a "cosmetic disturbance " , [32] although it has been associated with a rapid recurrence of tense ascites and shorter survival. [24] According to the definition 73.3% of the patients of 28 variables including demographic, clinical data as well as liver and renal tests was found to have an independent predictive value for the development of PICD. [35] To the best of our knowledge no other study reported that age had an effect on PICD. The fact that younger age immerged as an independent predictor, merits further study of whether older age blunts the vasoactive response and hence protects against PICD. It has to be noted that age is a non modifi able risk factor since it is not possible to deny younger patients the benefi t of LVP if they need it.
In this study, the echocardiographic fi ndings at base line has shown that the patients already had a hyperdynamic circulatory state as indicated by the higher heart rate and cardiac output and lower mean arterial blood pressure than normal. These findings are in agreement with several studies of cirrhotic patients with and without ascites, [36] [37] [38] and has been explained by several factors including: increased sympathetic nervous activity, increased blood volume (increased preload), and the presence of arteriovenous communications. [39] [40] [41] Forty eight hours after LVP the hyperdynamic circulatory state was accentuated as seen by the signifi cant increase in HR and COP and signifi cant decrease in MAP. These fi ndings confi rm earlier reports of heamodynamic changes early after paracentesis [42, 43] that have been considered to have a favorable effect on alleviating some symptoms that characterize cirrhotic patients with ascites. [44, 32] These early haemodynamic changes have been explained by the dynamics of paracentesis itself (short duration and higher fl ow rate of paracentesis), [45, 46] local abdominal mechanical factors, [47] or a refl ex of the stimulation of cardiac-volume receptors inhibiting sympathetic vasoconstrictive tone and renal release of rennin via an increase of cardiac volume. [42] Our results show that the accentuation of the hyperdynamic circulation 48 hours after LVP occurred in both those who did and did not develop PICD although the extent of change of HR, COP and MAP was higher among those who developed PICD than those who did not. This is in accordance with the fi ndings of Ruiz del Arbol et al. who demonstrated a signifi cant inverse correlation between changes in systemic vascular resistance (SVR) and PRA on day 6 after ascites removal. [21] This fi nding strongly suggests that PICD could be caused by enhancement of peripheral arterial vasodilatation that characterize these patients. [47] Hence it has been suggested that the use of arteriolar vasoconstrictors as terilipressin [48, 49] or noradrenaline, [50] could be useful in preventing this complication.
The hemodynamic changes observed in this study would support the recent hypothesis that immediately after paracentesis, an effective hypovolaemia due to accentuation of arteriolar vasodilatation occurs. The origin of this vasodilatation is probably multifactorial and includes an abrupt decrease in intra abdominal Pressure, a refl ex mechanism via the increase in cardiac output and an increased release of nitric oxide, likely to be secondary to shear stress. In response to this vasodilatation, activation of the renin-angiotensin and sympathetic nervous systems takes place. Patients who are able to compensate for this vasodilatation in the fi rst few days after paracentesis will not develop PICD and the levels of PRA will return to baseline. However, PICD will develop in those who are unable to compensate. The degree of hyporesponsiveness to vasoconstrictors could play an important role in this setting " . [32] As regards the cardiac functional status at base line, there was evidence of left ventricular diastolic dysfunction as indicated by the signifi cantly reduced E/A ratio, but no evidence of ventricular systolic dysfunction as evidenced by the normal EF and ventricular wall thickness (PwT and IVwT). These fi ndings are similar to most other echocardiographic studies of cirrhotic ascetic patients that showed alteration in diastolic, but not systolic function. [42, [50] [51] [52] [53] In contrast other studies suggested both systolic and diastolic ventricular dysfunction in alcoholic, [54] and non alcoholic cirrhotic patients. [55, 56] After 48 hours from LVP there was no change in the echocardiographic parameters of ventricular function from base line except a signifi cant marginal increase in EF within the normal range. The latter fi nding is in agreement with that of Pozzi et al, 1997 who reported that the ventricular ejection fraction in cirrhotic patients with tense ascites was somewhat less than the control and non ascitic patients, with tendency to increase after large volume paracentesis. However, our fi ndings are in contrast with their fi nding that removal of ascitic fl uid by large volume paracentesis reduces the A wave velocity and increases the E/A ratio in patients with tense ascites. [56] Consequently the functional cardic parameters before or after LVP in this study did not refl ect on the occurrence of PICD. [57] It is really confi rmed that ascites is a feature of advanced liver disease related to cirrhosis so it really important to recognize.
CONCLUSION
Large volume paracentesis has been found to be safe and effective in the treatment of cirrhotic patients with tense/refractory ascites. Salt free human albumin is the plasma expander of choice especially if at least 8 liters are evacuated. The ventricular diastolic faunction is alter in cirrhotic patients with tense ascites. This might represent an early compensated stage of cardiomyopathy, but was not affected by LVP and did not refl ect on the occurrence of PICD.
